Literature DB >> 12843092

Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans.

Jean O Kim1, Lucille Garofalo, Deborah Blecker-Shelly, Karin L McGowan.   

Abstract

Candida dubliniensis is a recently described species that shares many phenotypic and morphological features with Candida albicans. The clinical significance of isolating C. dubliniensis from the pediatric population is not clear, as most clinical isolates have been recovered from the oral cavities or bloodstreams of adults infected with human immunodeficiency virus. In order to understand further the epidemiology of C. dubliniensis in our pediatric population, we identified C. dubliniensis isolates from clinical isolates previously identified in the laboratory as C. albicans and conducted a retrospective chart review of cases of C. dubliniensis infections. A total of 205 isolates from 183 patients were tested, and only 14 (6.8%) were identified as C. dubliniensis. In 5 of the 14 positive cultures, C. dubliniensis was the sole organism isolated (two respiratory tract specimens, one tongue specimen, one vaginal specimen, and one skin specimen). A case review showed that there were no adverse outcomes for any of the patients, and only one of the patients with cultures positive for C. dubliniensis was immunocompromised. In our pediatric population, the distinction of C. dubliniensis from C. albicans did not prove to have significant clinical relevance. Data from further investigations may help to define better the role of C. dubliniensis as a potential pathogen in children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843092      PMCID: PMC165386          DOI: 10.1128/JCM.41.7.3354-3357.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Candida dubliniensis at a cancer center.

Authors:  A Sebti; T E Kiehn; D Perlin; V Chaturvedi; M Wong; A Doney; S Park; K A Sepkowitz
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

2.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States.

Authors:  I F Salkin; W R Pruitt; A A Padhye; D Sullivan; D Coleman; D H Pincus
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.

Authors:  Kaaren G Vargas; Sophie Joly
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Candida dubliniensis fungemia and vascular access infection.

Authors:  Nevio Cimolai; Jeff Davis; Colleen Trombley
Journal:  J Pediatr Hematol Oncol       Date:  2002 Mar-Apr       Impact factor: 1.289

6.  Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.

Authors:  D M Brown; M A Jabra-Rizk; W A Falkler; A A Baqui; T F Meiller
Journal:  Pediatr Dent       Date:  2000 May-Jun       Impact factor: 1.874

7.  Recovery of Candida dubliniensis from sputum of cystic fibrosis patients.

Authors:  Heidrun Peltroche-Llacsahuanga; Hiltrud Döhmen; Gerhard Haase
Journal:  Mycoses       Date:  2002-02       Impact factor: 4.377

8.  Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

Authors:  J F Meis; M Ruhnke; B E De Pauw; F C Odds; W Siegert; P E Verweij
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

9.  Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans.

Authors:  M M S Vilela; K Kamei; A Sano; R Tanaka; J Uno; I Takahashi; J Ito; K Yarita; M Miyaji
Journal:  Med Mycol       Date:  2002-06       Impact factor: 4.076

10.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

View more
  5 in total

1.  The first clinical isolates of Candida dubliniensis in Slovakia.

Authors:  Silvia Melkusovà; Magdalèna Lisalovà; Peter Pavlìk; Helena Bujdàkovà
Journal:  Mycopathologia       Date:  2005-04       Impact factor: 2.574

2.  The first documented case of Candida dubliniensis leptomeningeal disease in an immunocompetent host.

Authors:  Nicholas H Andrew; Ravi P Ruberu; Genevieve Gabb
Journal:  BMJ Case Rep       Date:  2011-08-04

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

4.  Methods of Candida dubliniensis identification and its occurrence in human clinical material.

Authors:  Martina Mahelová; Filip Růžička
Journal:  Folia Microbiol (Praha)       Date:  2017-05-17       Impact factor: 2.099

5.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.